copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
News - Visus Therapeutics™ Check back often for the very latest updates, announcements, and breakthroughs that are propelling us forward Visus Therapeutics is a clinical-stage company focused on developing innovative ophthalmic therapies to improve vision for people around the world
Visus closes in on AbbVie with midphase data on long-sightedness eye drop Visus’ eye drop is further back, but the phase 2 data point to the potential for it to deliver a differentiated candidate Notably, the midphase results provide early evidence in support of Visus’ framing of brimochol as a longer-lasting treatment Read the full article here
Visus Initiates Phase 3 Trial of Brimochol PF to Treat Presbyopia The first of two pivotal phase 3 trials that will assess the safety and efficacy of Brimochol PF for the treatment of presbyopia is underway, according to a press release from Visus Therapeutics
New options are on the horizon for presbyopia-correcting drops Presbyopia is a natural consequence of ageing It affects more than 1 billion individuals globally and approximately 123 million in the United States Over the years, many surgical approaches to the correction of the condition have been attempted, but none has yet become widely adopted for patients without significant cataract Dr Marguerite B McDonaldNew options are on the horizon for
Careers - Visus Therapeutics™ With two offices in beautiful West Coast locations, Seattle, Washington and Orange County, California, we offer a warm, inclusive, and vibrant atmosphere in which our employees thrive Join the Visus “spark”! Check out our current job openings and follow us on LinkedIn